Cargando…

Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia

BACKGROUND: Sarcopenia is defined as the disease of muscle loss and dysfunction. The prevalence of sarcopenia is strongly age-dependent. It could bring about disability, hospitalization, and mortality. The purpose of this study was to identify plasma metabolites associated with possible sarcopenia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Chi-Jen, Lin, Chih-Ming, Fan, Chun-Ming, Tang, Hsiang-Yu, Liu, Han-Fang, Ho, Hung-Yao, Cheng, Mei-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666394/
https://www.ncbi.nlm.nih.gov/pubmed/37993772
http://dx.doi.org/10.1186/s12877-023-04485-x
_version_ 1785148940389187584
author Lo, Chi-Jen
Lin, Chih-Ming
Fan, Chun-Ming
Tang, Hsiang-Yu
Liu, Han-Fang
Ho, Hung-Yao
Cheng, Mei-Ling
author_facet Lo, Chi-Jen
Lin, Chih-Ming
Fan, Chun-Ming
Tang, Hsiang-Yu
Liu, Han-Fang
Ho, Hung-Yao
Cheng, Mei-Ling
author_sort Lo, Chi-Jen
collection PubMed
description BACKGROUND: Sarcopenia is defined as the disease of muscle loss and dysfunction. The prevalence of sarcopenia is strongly age-dependent. It could bring about disability, hospitalization, and mortality. The purpose of this study was to identify plasma metabolites associated with possible sarcopenia and muscle function to improve disease monitoring and understand the mechanism of muscle strength and function decline. METHODS: The participants were a group of healthy older adult who live in retirement homes in Asia (Taiwan) and can manage their daily lives without assistance. The participants were enrolled and divided into four groups: control (Con, n = 57); low physical function (LPF, n = 104); sarcopenia (S, n = 63); and severe sarcopenia (SS, n = 65) according to Asian countries that used Asian Working Group for Sarcopenia (AWGS) criteria. The plasma metabolites were used and the results were calculated as the difference between the control and other groups. RESULTS: Clinical parameters, age, gender, body mass index (BMI), hand grip strength (HGS), gait speed (GS), blood urea nitrogen (BUN), hemoglobin, and hematocrit were significantly different between the control and LPF groups. Metabolite patterns of LPF, S, and SS were explored in our study. Plasma kynurenine (KYN) and acylcarnitines (C0, C4, C6, and C18:1-OH) were identified with higher concentrations in older Taiwanese adults with possible sarcopenia and S compared to the Con group. After multivariable adjustment, the data indicate that age, BMI, and butyrylcarnitine (C4) are more important factors to identify individuals with low physical function and sarcopenia. CONCLUSION: This metabolomic study raises the importance of acylcarnitines on muscle mass and function. It suggests that age, BMI, BUN, KYN, and C4/Cr can be important evaluation markers for LPF (AUC: 0.766), S (AUC: 0.787), and SS (AUC: 0.919). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-04485-x.
format Online
Article
Text
id pubmed-10666394
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106663942023-11-22 Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia Lo, Chi-Jen Lin, Chih-Ming Fan, Chun-Ming Tang, Hsiang-Yu Liu, Han-Fang Ho, Hung-Yao Cheng, Mei-Ling BMC Geriatr Research BACKGROUND: Sarcopenia is defined as the disease of muscle loss and dysfunction. The prevalence of sarcopenia is strongly age-dependent. It could bring about disability, hospitalization, and mortality. The purpose of this study was to identify plasma metabolites associated with possible sarcopenia and muscle function to improve disease monitoring and understand the mechanism of muscle strength and function decline. METHODS: The participants were a group of healthy older adult who live in retirement homes in Asia (Taiwan) and can manage their daily lives without assistance. The participants were enrolled and divided into four groups: control (Con, n = 57); low physical function (LPF, n = 104); sarcopenia (S, n = 63); and severe sarcopenia (SS, n = 65) according to Asian countries that used Asian Working Group for Sarcopenia (AWGS) criteria. The plasma metabolites were used and the results were calculated as the difference between the control and other groups. RESULTS: Clinical parameters, age, gender, body mass index (BMI), hand grip strength (HGS), gait speed (GS), blood urea nitrogen (BUN), hemoglobin, and hematocrit were significantly different between the control and LPF groups. Metabolite patterns of LPF, S, and SS were explored in our study. Plasma kynurenine (KYN) and acylcarnitines (C0, C4, C6, and C18:1-OH) were identified with higher concentrations in older Taiwanese adults with possible sarcopenia and S compared to the Con group. After multivariable adjustment, the data indicate that age, BMI, and butyrylcarnitine (C4) are more important factors to identify individuals with low physical function and sarcopenia. CONCLUSION: This metabolomic study raises the importance of acylcarnitines on muscle mass and function. It suggests that age, BMI, BUN, KYN, and C4/Cr can be important evaluation markers for LPF (AUC: 0.766), S (AUC: 0.787), and SS (AUC: 0.919). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-04485-x. BioMed Central 2023-11-22 /pmc/articles/PMC10666394/ /pubmed/37993772 http://dx.doi.org/10.1186/s12877-023-04485-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lo, Chi-Jen
Lin, Chih-Ming
Fan, Chun-Ming
Tang, Hsiang-Yu
Liu, Han-Fang
Ho, Hung-Yao
Cheng, Mei-Ling
Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title_full Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title_fullStr Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title_full_unstemmed Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title_short Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
title_sort plasma acylcarnitine in elderly taiwanese: as biomarkers of possible sarcopenia and sarcopenia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666394/
https://www.ncbi.nlm.nih.gov/pubmed/37993772
http://dx.doi.org/10.1186/s12877-023-04485-x
work_keys_str_mv AT lochijen plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT linchihming plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT fanchunming plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT tanghsiangyu plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT liuhanfang plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT hohungyao plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia
AT chengmeiling plasmaacylcarnitineinelderlytaiwaneseasbiomarkersofpossiblesarcopeniaandsarcopenia